|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/426 | |
| A61K 9/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 3377061 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16812992.2 |
| Date of filing the European patent application | 2016-11-17 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/FR2016/052981 |
| Date | 2016-11-17 |
| (87) | Number | WO 2017/085407 |
| Date | 2017-05-26 |
| (30) | Number | Date | Country code |
| 1561067 | 2015-11-17 | FR |
| (72) |
FONTAINE, Valérie, FR
VIDAL, Cécile, FR
SAHEL, José-Alain, FR
|
| (73) |
INSERM (Institut National de la Santé et de la Recherche Médicale),
101, rue de Tolbiac, 75654 Paris Cedex 13,
FR
Centre National de la Recherche Scientifique, 3, rue Michel-Ange, 75016 Paris, FR Sorbonne Université, 21 Rue de l`Ecole de Médecine, 75006 Paris, FR |
| (54) | MIRABÉGRON POUR LE TRAITEMENT DE MALADIES RÉTINIENNES |
| MIRABEGRON FOR THE TREATMENT OF RETINAL DISEASES |